Abstract

Positron emission tomography (PET)/computed tomography (CT), which combines the advantages of high sensitivity and specificity of PET and high resolution of CT, is a unique tool for cancer management. PET/CT has been widely used in cancer diagnosis and treatment. The article reviews the recent applications of PET/CT in radiation oncology, with a focus on 18F-fluorodeoxyglucose (FDG)-PET/CT, addressing the applications in treatment planning and treatment response assessment of radiation therapy.

Highlights

  • With high sensitivity and specificity, positron emission tomography (PET) is playing an important role in cancer imaging and treatment (Histed et al, 2012; Sveistrup et al, 2012)

  • PET/computed tomography (CT) has been successfully used in the diagnosis, initial staging, and response assessment in various malignant tumors with high diagnostic accuracy (Borst et al, 2005; Eschmann et al, 2006; Facey et al, 2007) and has been used for PET-guided radiation treatment planning (Jarritt et al, 2006; Gregoire et al, 2007). 18Ffluorodeoxyglucose (FDG) is the only Medicare approved PET/CT tracer for cancer imaging and FDG-PET/CT is the most widely available PET/CT procedure used in daily oncology practice

  • This study is to review the recent applications of PET/CT in radiation oncology, i.e., in radiation treatment response assessment and treatment planning, with a focus on FDG-PET/CT

Read more

Summary

INTRODUCTION

With high sensitivity and specificity, positron emission tomography (PET) is playing an important role in cancer imaging and treatment (Histed et al, 2012; Sveistrup et al, 2012). PET/CT showed high sensitivity and specificity for mediastinal lymph node involvement over CT. PET/CT has showed high sensitivity and specificity in initial staging and restaging cervical cancer and PET/CT has the advantage of detecting gross para-aortic and pelvic lymph nodes (PLNs) for treatment planning, which CT may not be able to detect. Radiation treatment can be improved by using PET/CT for target volume delineation: doses to the tumor can be increased and organs at risk (OARs) can be spared. Positron emission tomography/CT images are used in two ways in radiation treatment planning: for PET/CT images acquired from a diagnostic scanner, the images are registered/fused with planning CT images; for PET/CT images acquired on a dedicated planning PET/CT scanner, the images are directly used www.frontiersin.org

Head and neck
NSCLC Head and neck
Findings
CONCLUSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.